Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.

Avery RA, Bouffet E, Packer RJ, Reginald A.

Invest Ophthalmol Vis Sci. 2013 Feb 5;54(2):1034-8. doi: 10.1167/iovs.12-11385.

PMID:
23329671
2.

Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.

Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC.

J AAPOS. 2010 Apr;14(2):155-8. doi: 10.1016/j.jaapos.2009.11.020.

PMID:
20451859
3.

Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.

Chang BC, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, Westall CA, Buncic JR.

Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2895-902.

PMID:
17525226
4.

Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.

de Blank PM, Berman JI, Liu GT, Roberts TP, Fisher MJ.

Neuro Oncol. 2013 Aug;15(8):1088-95. doi: 10.1093/neuonc/not068. Epub 2013 May 7.

5.
6.

Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.

Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT.

Neuro Oncol. 2012 Jun;14(6):790-7. doi: 10.1093/neuonc/nos076. Epub 2012 Apr 3.

7.

The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1.

Prada CE, Hufnagel RB, Hummel TR, Lovell AM, Hopkin RJ, Saal HM, Schorry EK.

J Pediatr. 2015 Oct;167(4):851-856.e1. doi: 10.1016/j.jpeds.2015.07.001. Epub 2015 Jul 29.

PMID:
26233602
8.

[Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].

Schröder S, Baumann-Schröder U, Hazim W, Haase W, Mautner VF.

Klin Monbl Augenheilkd. 1999 Dec;215(6):349-54. German.

PMID:
10637799
9.

Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome.

King A, Listernick R, Charrow J, Piersall L, Gutmann DH.

Am J Med Genet A. 2003 Oct 1;122A(2):95-9.

PMID:
12955759
10.

Visual acuity of children treated with chemotherapy for optic pathway gliomas.

Kalin-Hajdu E, Décarie JC, Marzouki M, Carret AS, Ospina LH.

Pediatr Blood Cancer. 2014 Feb;61(2):223-7. doi: 10.1002/pbc.24726. Epub 2013 Aug 19.

PMID:
23956233
11.

Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.

Balcer LJ, Liu GT, Heller G, Bilaniuk L, Volpe NJ, Galetta SL, Molloy PT, Phillips PC, Janss AJ, Vaughn S, Maguire MG.

Am J Ophthalmol. 2001 Apr;131(4):442-5.

PMID:
11292406
12.

Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

Listernick R, Ferner RE, Liu GT, Gutmann DH.

Ann Neurol. 2007 Mar;61(3):189-98. Review.

PMID:
17387725
13.

Comparison of the HOTV and Lea symbols visual acuity tests in patients with amblyopia.

Ruttum MS, Dahlgren M.

J Pediatr Ophthalmol Strabismus. 2006 May-Jun;43(3):157-60.

PMID:
16761636
14.

Visual loss in orbitofacial neurofibromatosis type 1.

Oystreck DT, Morales J, Chaudhry I, Alorainy IA, Elkhamary SM, Pasha TM, Bosley TM.

Ophthalmology. 2012 Oct;119(10):2168-73. doi: 10.1016/j.ophtha.2012.04.032. Epub 2012 Jun 17.

PMID:
22709421
15.

Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.

Thiagalingam S, Flaherty M, Billson F, North K.

Ophthalmology. 2004 Mar;111(3):568-77. Review.

PMID:
15019338
16.

Ophthalmological assessment of children with neurofibromatosis type 1.

Cassiman C, Legius E, Spileers W, Casteels I.

Eur J Pediatr. 2013 Oct;172(10):1327-33. doi: 10.1007/s00431-013-2035-2. Epub 2013 May 25. Review.

PMID:
23708214
18.

Functional outcome measures for NF1-associated optic pathway glioma clinical trials.

Fisher MJ, Avery RA, Allen JC, Ardern-Holmes SL, Bilaniuk LT, Ferner RE, Gutmann DH, Listernick R, Martin S, Ullrich NJ, Liu GT; REiNS International Collaboration.

Neurology. 2013 Nov 19;81(21 Suppl 1):S15-24. doi: 10.1212/01.wnl.0000435745.95155.b8.

19.

Vision specific quality of life in children with optic pathway gliomas.

Avery RA, Hardy KK.

J Neurooncol. 2014 Jan;116(2):341-7. doi: 10.1007/s11060-013-1300-6. Epub 2013 Nov 7.

20.

Normative visual acuity in infants and preschool-aged children in Sydney.

Leone JF, Mitchell P, Kifley A, Rose KA; Sydney Childhood Eye Studies.

Acta Ophthalmol. 2014 Nov;92(7):e521-9. doi: 10.1111/aos.12366. Epub 2014 Mar 9.

Items per page

Supplemental Content

Write to the Help Desk